Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology.

Kuhajda FP.

Nutrition. 2000 Mar;16(3):202-8. Review.

PMID:
10705076
2.
3.

Oncogenic properties of the endogenous fatty acid metabolism: molecular pathology of fatty acid synthase in cancer cells.

Menendez JA, Lupu R.

Curr Opin Clin Nutr Metab Care. 2006 Jul;9(4):346-57. Review.

PMID:
16778562
6.

Fatty acid synthase activity in tumor cells.

Little JL, Kridel SJ.

Subcell Biochem. 2008;49:169-94. doi: 10.1007/978-1-4020-8831-5_7. Review.

PMID:
18751912
8.

Fatty acid synthase: a metabolic oncogene in prostate cancer?

Baron A, Migita T, Tang D, Loda M.

J Cell Biochem. 2004 Jan 1;91(1):47-53. Review.

PMID:
14689581
9.

Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis.

Menendez JA, Lupu R.

Nat Rev Cancer. 2007 Oct;7(10):763-77. Review.

PMID:
17882277
10.

Hyperglycaemia confers resistance to chemotherapy on breast cancer cells: the role of fatty acid synthase.

Zeng L, Biernacka KM, Holly JM, Jarrett C, Morrison AA, Morgan A, Winters ZE, Foulstone EJ, Shield JP, Perks CM.

Endocr Relat Cancer. 2010 May 18;17(2):539-51. doi: 10.1677/ERC-09-0221.

11.

Fatty acid synthase inhibitors: new directions for oncology.

Kridel SJ, Lowther WT, Pemble CW 4th.

Expert Opin Investig Drugs. 2007 Nov;16(11):1817-29. Review.

PMID:
17970640
12.
13.
15.

Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells.

Pizer ES, Jackisch C, Wood FD, Pasternack GR, Davidson NE, Kuhajda FP.

Cancer Res. 1996 Jun 15;56(12):2745-7.

17.

Fatty acid synthase and cancer: new application of an old pathway.

Kuhajda FP.

Cancer Res. 2006 Jun 15;66(12):5977-80. Review.

18.

Increased lipogenesis in cancer cells: new players, novel targets.

Swinnen JV, Brusselmans K, Verhoeven G.

Curr Opin Clin Nutr Metab Care. 2006 Jul;9(4):358-65. Review.

PMID:
16778563
20.

Fatty acid synthase inhibition activates AMP-activated protein kinase in SKOV3 human ovarian cancer cells.

Zhou W, Han WF, Landree LE, Thupari JN, Pinn ML, Bililign T, Kim EK, Vadlamudi A, Medghalchi SM, El Meskini R, Ronnett GV, Townsend CA, Kuhajda FP.

Cancer Res. 2007 Apr 1;67(7):2964-71.

Items per page

Supplemental Content

Support Center